Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Other Non-Current Liabilities (2016 - 2025)

Cellectis (CLLS) has 6 years of Other Non-Current Liabilities data on record, last reported at $2.4 million in Q4 2022.

  • For Q4 2022, Other Non-Current Liabilities rose 281.79% year-over-year to $2.4 million; the TTM value through Dec 2022 reached $2.4 million, up 281.79%, while the annual FY2022 figure was $2.4 million, 281.79% up from the prior year.
  • Other Non-Current Liabilities reached $2.4 million in Q4 2022 per CLLS's latest filing, up from $626000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $4.0 million in Q4 2020 and bottomed at $626000.0 in Q4 2021.
  • Average Other Non-Current Liabilities over 4 years is $2.4 million, with a median of $2.5 million recorded in 2018.
  • Peak YoY movement for Other Non-Current Liabilities: tumbled 84.39% in 2021, then soared 281.79% in 2022.
  • A 4-year view of Other Non-Current Liabilities shows it stood at $2.7 million in 2018, then skyrocketed by 49.57% to $4.0 million in 2020, then crashed by 84.39% to $626000.0 in 2021, then skyrocketed by 281.79% to $2.4 million in 2022.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $2.4 million in Q4 2022, $626000.0 in Q4 2021, and $4.0 million in Q4 2020.